Helmy Eltoukhy, Ph.D.

Dr. Helmy Eltoukhy is the Chairman and co-CEO of the leading precision oncology company Guardant Health, Inc, which he co-founded in 2012 with Dr. AmirAli Talasaz. In 2007, Helmy co-founded Avantome to commercialize semiconductor sequencing which was acquired by Illumina in 2008. While at Illumina, Helmy served as Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware, and informatics for genetic analysis systems. Helmy received his Ph.D., M.S. and B.S. degrees in electrical engineering from Stanford University, and he joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies.